Seronegative spondyloarthritis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 2: | Line 2: | ||
{{Seronegative spondyloarthritis}} | {{Seronegative spondyloarthritis}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}}{{Anmol}} | ||
==Overview== | ==Overview== | ||
Line 18: | Line 18: | ||
==Classification Criteria== | ==Classification Criteria== | ||
===ASAS classification criteria for axial spondyloarthritis (axial SpA)=== | ===ASAS classification criteria for axial spondyloarthritis (axial SpA)=== | ||
The Assessment of SpondyloArthritis | The Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (axial SpA) include:<ref name="pmid19297344">{{cite journal| author=Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J et al.| title=The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. | journal=Ann Rheum Dis | year= 2009 | volume= 68 | issue= 6 | pages= 777-83 | pmid=19297344 | doi=10.1136/ard.2009.108233 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19297344 }} </ref> | ||
*Patient with back pain ≥ 3 months and age of onset <45 years should fulfill either of the two criteria: | *Patient with back pain ≥ 3 months and age of onset <45 years should fulfill either of the two criteria: | ||
*# Sacroiliitis on imaging<sup>'''*'''</sup> plus ≥ 1 feature of SpA<sup>'''**'''</sup> | *# [[Sacroiliitis]] on imaging<sup>'''*'''</sup> plus ≥ 1 feature of SpA<sup>'''**'''</sup> | ||
*# HLA-B27 plus ≥ 2 feature of SpA<sup>'''**'''</sup> | *# [[HLA-B27]] plus ≥ 2 feature of SpA<sup>'''**'''</sup> | ||
:::<sup>'''*'''</sup>'''Sacroiliitis on imaging:''' | :::<sup>'''*'''</sup>'''Sacroiliitis on imaging:''' | ||
:::*Active (acute) inflammation on MRI highly suggestive of sacroiliitis associated with SpA | :::*Active (acute) [[inflammation]] on [[MRI]] highly suggestive of [[sacroiliitis]] associated with SpA | ||
:::::::OR | :::::::OR | ||
:::*Definite radiographic sacroillitis accorging to modified New York criteria | :::*Definite radiographic [[sacroillitis]] accorging to modified New York criteria | ||
:::<sup>'''**'''</sup>'''SpA features:''' | :::<sup>'''**'''</sup>'''SpA features:''' | ||
:::*Inflammatroy back pain | :::*Inflammatroy [[back pain]] | ||
:::*Arthritis | :::*[[Arthritis]] | ||
:::* | :::*[[Enthesitis]] (heel) | ||
:::*Uveitis | :::*[[Uveitis]] | ||
:::*Dactylitis | :::*[[Dactylitis]] | ||
:::*Psoriasis | :::*[[Psoriasis]] | ||
:::*Crohn's disease or ulcerative colitis | :::*[[Crohn's disease]] or [[ulcerative colitis]] | ||
:::*Good response to NSAIDs | :::*Good response to [[NSAIDs]] | ||
:::*Family history for SpA | :::*Family history for SpA | ||
:::*HLA-B27 | :::*[[HLA-B27]] | ||
:::*Elevated CRP | :::*Elevated [[CRP]] | ||
===ASAS classification criteria for peripheral spondyloarthritis=== | ===ASAS classification criteria for peripheral spondyloarthritis=== | ||
*The Assessment of SpondyloArthritis | *The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis (peripheral SpA) include:<ref name="pmid21163805">{{cite journal| author=Zeidler H, Amor B| title=The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress. | journal=Ann Rheum Dis | year= 2011 | volume= 70 | issue= 1 | pages= 1-3 | pmid=21163805 | doi=10.1136/ard.2010.135889 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21163805 }} </ref> | ||
:'''Arthritis or Enthesitis or Dactylitis''' | :'''Arthritis or Enthesitis or Dactylitis''' | ||
: '''PLUS ≥ 1 of:''' | : '''PLUS ≥ 1 of:''' | ||
:*Psoriasis | :*[[Psoriasis]] | ||
:*Inflammatory bowel disease | :*[[Inflammatory bowel disease]] | ||
:*Preceding infection | :*Preceding [[infection]] | ||
:*HLA-B27 | :*[[HLA-B27]] | ||
:*Uveitis | :*[[Uveitis]] | ||
:*Sacroiliitis on imaging (radiograph or MRI) | :*[[Sacroiliitis]] on imaging (radiograph or MRI) | ||
: '''PLUS ≥ 2 of:''' | : '''PLUS ≥ 2 of:''' | ||
:*Arthritis | :*[[Arthritis]] | ||
:* | :*[[Enthesitis]] | ||
:*Dactylitis | :*[[Dactylitis]] | ||
:*Inflammatory back pain in the past | :*Inflammatory [[back pain]] in the past | ||
:*Positive family history of SpA | :*Positive family history of SpA | ||
Line 62: | Line 62: | ||
{| class="wikitable" | {| class="wikitable" | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Arthritis Type | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Arthritis Type | ||
! colspan=" | ! colspan="5" align="center" style="background:#4479BA; color: #FFFFFF;" ! + |Clinical Features | ||
! colspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" ! + |Body Distribution | ! colspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" ! + |Body Distribution | ||
! colspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" ! + |Key Signs | ! colspan="4" align="center" style="background:#4479BA; color: #FFFFFF;" ! + |Key Signs | ||
Line 68: | Line 68: | ||
|- | |- | ||
| | | | ||
|'''Symmetric [[joint]] involvement''' | |'''Symmetric [[joint]] involvement''' | ||
|'''Asymmetric [[joint]] involvement''' | |'''Asymmetric [[joint]] involvement''' | ||
Line 88: | Line 87: | ||
|- | |- | ||
|'''[[Psoriatic arthritis]]''' | |'''[[Psoriatic arthritis]]''' | ||
| + | | + | ||
| ++ | | ++ | ||
Line 108: | Line 106: | ||
|- | |- | ||
|'''[[Rheumatoid arthritis]]''' | |'''[[Rheumatoid arthritis]]''' | ||
| ++ | | ++ | ||
| + | | + | ||
Line 129: | Line 126: | ||
|- | |- | ||
|'''[[Ankylosing spondylitis]]''' | |'''[[Ankylosing spondylitis]]''' | ||
| +++ | | +++ | ||
| - | | - | ||
Line 149: | Line 145: | ||
|- | |- | ||
|'''[[Reactive arthritis]] ([[Reiter's syndrome]])''' | |'''[[Reactive arthritis]] ([[Reiter's syndrome]])''' | ||
| +++ | | +++ | ||
| - | | - | ||
Line 168: | Line 163: | ||
|75% | |75% | ||
|- | |- | ||
|[[Enteropathic arthropathy|Inflammatory bowel disease-related arthritis]] | |[[Enteropathic arthropathy|'''Inflammatory bowel disease-related arthritis''']] | ||
| | | | ||
|<nowiki>++</nowiki> | |<nowiki>++</nowiki> | ||
Line 185: | Line 179: | ||
|<nowiki>+</nowiki> | |<nowiki>+</nowiki> | ||
| | | | ||
++ | ++ | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|50-75% | |50-75% | ||
|- | |- | ||
|Juvenile ankylosing spondyloarthritis | |'''Juvenile ankylosing spondyloarthritis''' | ||
| - | | - | ||
| ++ | | ++ | ||
Line 212: | Line 204: | ||
Key:+ : Infrequently present, ++ : Frequently present, +++ : Always present, - : Absent | Key:+ : Infrequently present, ++ : Frequently present, +++ : Always present, - : Absent | ||
==References== | ==References== |
Revision as of 16:50, 16 April 2018
Seronegative spondyloarthritis Main Page |
|
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
"Seronegative" refers to the fact that these diseases are negative for Rheumatoid factor and CCP in the serum.
Classification
Algorithm showing classification of seronegative spondyloarthritis[1]
Seronegative Spondyloarthritis (SpA) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Axial SpA including Ankylosing spondylitis | Peripheral SpA | Psoriatic arthritis | Reactive arthritis | Inflammatory bowel disease related arthritis | Juvenile spondyloarthritis | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Classification Criteria
ASAS classification criteria for axial spondyloarthritis (axial SpA)
The Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (axial SpA) include:[2]
- Patient with back pain ≥ 3 months and age of onset <45 years should fulfill either of the two criteria:
- Sacroiliitis on imaging* plus ≥ 1 feature of SpA**
- HLA-B27 plus ≥ 2 feature of SpA**
- *Sacroiliitis on imaging:
- Active (acute) inflammation on MRI highly suggestive of sacroiliitis associated with SpA
- OR
- Definite radiographic sacroillitis accorging to modified New York criteria
- **SpA features:
- Inflammatroy back pain
- Arthritis
- Enthesitis (heel)
- Uveitis
- Dactylitis
- Psoriasis
- Crohn's disease or ulcerative colitis
- Good response to NSAIDs
- Family history for SpA
- HLA-B27
- Elevated CRP
- *Sacroiliitis on imaging:
ASAS classification criteria for peripheral spondyloarthritis
- The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis (peripheral SpA) include:[3]
- Arthritis or Enthesitis or Dactylitis
- PLUS ≥ 1 of:
- Psoriasis
- Inflammatory bowel disease
- Preceding infection
- HLA-B27
- Uveitis
- Sacroiliitis on imaging (radiograph or MRI)
- PLUS ≥ 2 of:
- Arthritis
- Enthesitis
- Dactylitis
- Inflammatory back pain in the past
- Positive family history of SpA
Differential Diagnosis
Arthritis Type | Clinical Features | Body Distribution | Key Signs | Laboratory Abnormalities | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symmetric joint involvement | Asymmetric joint involvement | Enthesopathy | Dactylitis | Nail Dystrophy | Upper extremity-hands | Lower extremity | Sacroiliac joints | Spine | Osteopenia | Joint Space | Ankylosis | Periostitis | Soft tissue swelling | ESR | Rheumatoid factor (RF) | HLA-B27 | |
Psoriatic arthritis | + | ++ | + | + | + | +++ (DIP/PIP) | +++ | ++ (Unilateral) | ++ | - | ++ (Widening) | ++ | +++ (Fluffy) | ++ | + | - | 30-75% |
Rheumatoid arthritis | ++ | + | - | - | - | +++ | +++ | + (Unilateral) | ++(Cervical) | +++ | +++ (Narrowing) | + | + (Linear) | +++ | +++ | +++ | 6-8% |
Ankylosing spondylitis | +++ | - | + | - | - | + | + | +++ (Bilateral) | +++ | +++ | ++ (Narrowing) | +++ | +++ (Fluffy) | + | +++ | - | 90% |
Reactive arthritis (Reiter's syndrome) | +++ | - | + | + | - | ++ | +++ | ++ (Unilateral) | + | + | + (Narrowing) | - | +++ (Fluffy) | ++ | ++ | - | 75% |
Inflammatory bowel disease-related arthritis | ++ | + | + | - | ++ | ++ | +++ (Bilateral) | + | + | ++ (Widening) | + | + | + |
++ |
- | 50-75% | |
Juvenile ankylosing spondyloarthritis | - | ++ | ++ | + | + | + | +++ | +++ | ++ | - | - | +++ | - | ++ | + | - | 90% |
Key:+ : Infrequently present, ++ : Frequently present, +++ : Always present, - : Absent
References
- ↑ Dougados M, Baeten D (2011). "Spondyloarthritis". Lancet. 377 (9783): 2127–37. doi:10.1016/S0140-6736(11)60071-8. PMID 21684383.
- ↑ Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J; et al. (2009). "The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection". Ann Rheum Dis. 68 (6): 777–83. doi:10.1136/ard.2009.108233. PMID 19297344.
- ↑ Zeidler H, Amor B (2011). "The Assessment in Spondyloarthritis International Society (ASAS) classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general: the spondyloarthritis concept in progress". Ann Rheum Dis. 70 (1): 1–3. doi:10.1136/ard.2010.135889. PMID 21163805.